Answer:
drugs that make it all the way through development, testing, and regulatory acceptance, the pharmaceutical company then gives the drug a trade name, which is a standard term in the pharmaceutical industry for a brand name or trademark name.
Neurotransmitters would continue to bind and rebind with the postsynaptic receptors, which would continue induction of a signal in the postsynaptic neurons, which would repropagate the initial signal.
The case in drugs that block reuptake transporters (such as in serotonin reuptake inhibitor and norepinephrine reuptake inhibitor antidepressants, and dopamine reuptake inhibition found with cocaine and methylphenidate).
<span> its a primary care </span>center<span> that is community-based and patient-directed </span>
I'm pretty sure that would be false and would also go against some of the points of what your talking about. Not to mention it's rude to do so. I'm pretty sure anyways.
Hope that helps.
